Experimental findings demonstrate amyloid-beta fibrils catalyze ATP dephosphorylation to enhance calcium phosphate crystallization, indicating a role in Alzheimer disease pathology.
Brain-localized deposits of crystalline calcium phosphate, mainly comprising of hydroxyapatite, are a pathological hallmark of Alzheimer disease (AD). While calcium phosphate crystals are specifically identified in the neuronal amyloid plaques in AD, consisting mostly of beta amyloid (Aβ) fibrils, the mechanisms and factors affecting the biomineralization are unknown. Here, we present a novel mechanism for AD plaque-induced formation of crystalline calcium phosphate. Specifically, we show, for the first time, that Aβ amyloid fibrils catalyze dephosphorylation of adenosine triphosphate (ATP). Furthermore, incubating Aβ fibrils, ATP, and calcium ions gave rise to pronounced deposition of hydroxyapatite crystals upon the Aβ amyloid fibril matrix, originating through reaction between calcium ions and the monophosphate released through the catalytic dephosphorylation reaction. This pathway may explain amyloid plaque-associated calcification in AD, as elevated levels of both ATP and calcium are key features of the disease.
No takes yet. Share an insight, caveat, or question.
Kunnath et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: